Announcements Trials
Browse Landscape

Phase

Phase NA 126Phase 2 9Phase 3 7Phase 2/3 2Phase EARLY_PHASE1 1Phase 1/2 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Breast 2Other 1Head & Neck 1Genitourinary 1

Conditions

Obesity 1Motor Activity 1Breast Neoplasms 1Breast Cancer Prevention 1

Interventions

Capecitabine 17Paclitaxel 16Docetaxel 13Carboplatin 12Cyclophosphamide 11Gemcitabine 9Epirubicin 9Trastuzumab 8Letrozole 8Doxorubicin 7pertuzumab 5Cisplatin 5Vinorelbine 4130-nm albumin-bound paclitaxel 4exemestane 3Zoledronic Acid 3Tamoxifen 3Neoadjuvant Therapy 3Lapatinib 3Injections 3Drug Therapy 3Ado-Trastuzumab Emtansine 3AC protocol 3pyrotinib 2palbociclib 2camrelizumab 2apatinib 2Thiotepa 2Taxes 2Standard of Care 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Exercise × Breast × Clear all
NCT00393172 2019-11-01

WISER

University of Minnesota

Phase 2/3 Completed
400 enrolled
BreastOther

Breast Neoplasms, Motor Activity, Obesity

NCT00668174 2012-11-28

Effect of Exercise on Sex Hormones in Postmenopausal Women

Fred Hutchinson Cancer Center

Phase 2/3 Completed
173 enrolled
Breast

Breast Cancer Prevention

Data powered by HemOnc (CC BY 4.0) Colophon âš¡